World Orphan Drug Congress Europe 2025
Amsterdam
Netherlands
Del
to
Healthcare
Drug discovery
International

“The Start-to-Finish of Orphan Drugs. From regulation and policy to global pricing and gene therapy.
Covering cell & gene therapy, genetic testing, market access, real world evidence, orphan drugs policy and much more. 130+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions.
Networking is at the heart of World Orphan Drug Congress. Our congress allows you to connect directly with thousands of pharma experts across 3 days of built-in 1-2-1 networking.”
More information: World Orphan Drug Congress 2025 | Amsterdam
Advantage
AseBio members receive a 20% discount on registration.